Literature DB >> 33729624

A 43 Ca nuclear magnetic resonance perspective on octacalcium phosphate and its hybrid derivatives.

Danielle Laurencin1, Yang Li2, Melinda J Duer2, Dinu Iuga3, Christel Gervais4, Christian Bonhomme4.   

Abstract

43 Ca nuclear magnetic resonance (NMR) spectroscopy has been extensively applied to the detailed study of octacalcium phosphate (OCP), Ca8 (HPO4 )2 (PO4 )4 .5H2 O, and hybrid derivatives involving intercalated metabolic acids (viz., citrate, succinate, formate, and adipate). Such phases are of importance in the development of a better understanding of bone structure. High-resolution 43 Ca magic angle spinning (MAS) experiments, including double-rotation (DOR) 43 Ca NMR, as well as 43 Ca{1 H} rotational echo DOR (REDOR) and 31 P{43 Ca} REAPDOR NMR spectra, were recorded on a 43 Ca-labeled OCP phase at very high magnetic field (20 T), and complemented by ab initio calculations of NMR parameters using the Gauge-Including Projector Augmented Wave-density functional theory (GIPAW-DFT) method. This enabled a partial assignment of the eight inequivalent Ca2+ sites of OCP. Natural-abundance 43 Ca MAS NMR spectra were then recorded for the hybrid organic-inorganic derivatives, revealing changes in the 43 Ca lineshape. In the case of the citrate derivative, these could be interpreted on the basis of computational models of the structure. Overall, this study highlights the advantages of combining high-resolution 43 Ca NMR experiments and computational modeling for studying complex hybrid biomaterials.
© 2021 John Wiley & Sons, Ltd.

Entities:  

Keywords:  43Ca solid state NMR; biomaterials; hybrid organic-inorganic composites; metabolic acids; octa-calcium phosphate Ca8(HPO4)2(PO4)4.5H2O; quadrupolar nuclei

Year:  2021        PMID: 33729624     DOI: 10.1002/mrc.5149

Source DB:  PubMed          Journal:  Magn Reson Chem        ISSN: 0749-1581            Impact factor:   2.447


  1 in total

Review 1.  Octacalcium phosphate with incorporated carboxylate ions: a review.

Authors:  Taishi Yokoi; Masaya Shimabukuro; Masakazu Kawashita
Journal:  Sci Technol Adv Mater       Date:  2022-07-20       Impact factor: 7.821

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.